
Flyte
Freedom from bladder leaks. in reach. | Flyte by Pelvital USA.
Date | Investors | Amount | Round |
---|---|---|---|
N/A | €0.0 | round | |
N/A | €0.0 | round | |
N/A | €0.0 | round | |
investor investor investor | €0.0 | round | |
* | $2.3m | Seed | |
Total Funding | 000k |
Related Content
Flyte by Pelvital offers a revolutionary at-home treatment for stress urinary incontinence, targeting women who experience bladder leaks, particularly after childbirth or during athletic activities. The company operates in the healthcare market, focusing on non-invasive solutions for pelvic floor strengthening. Flyte's core product is an intravaginal device that uses mechanotherapy and biofeedback to amplify the benefits of Kegel exercises, making them 39 times more effective. The device is designed to be used for just 5 minutes a day over a 6-week period, with a 90% user satisfaction rate for ease of use. Flyte generates revenue through direct sales of its device and offers a money-back guarantee if users do not see improved bladder control within six weeks. Additionally, the company provides free consultations with a pelvic floor physical therapist and educational resources through its Flyte Notes newsletter.
Keywords: stress urinary incontinence, pelvic floor, mechanotherapy, biofeedback, intravaginal device, Kegel exercises, bladder control, non-invasive treatment, women's health, healthcare innovation.